Advertisement

Plasma lipids in beta-thalassemia minor

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Because total cholesterol levels have been found to be lower in patients affected by thalassemia major and intermedia, we examined the plasma lipid pattern of 628 beta-thalassemia trait carriers and 4552 controls in order to evaluate whether the plasma lipid impairment is also present in the heterozygous state. Total cholesterol and low density lipoprotein (LDL)-cholesterol levels were significantly lower in betathalassemia trait carriers when compared to controls, whereas plasma triglycerides and high density lipoprotein (HDL)-cholestrol levels did not differ between the two groups. We suggest that accelerated erythropoiesis and increased uptake of LDL by macrophages and histiocytes of the reticuloendothelial system are the main determinants of low plasma cholesterol levels in heterozygous thalassemia.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Maioli M.
        • Cuccuru G.B.
        • Pranzetti P.
        • Pacifico A.
        • Cherchi G.M.
        Plasma lipids and lipoproteins pattern in beta- thalassemia major.
        Acta Haematol. 1984; 71: 106
        • Cherchi G.M.
        • Coinu R.
        • Deiana M.G.
        • Longinotti M.
        • Dore F.
        • Pacifico A.
        • Maioli M.
        Serum lipids and triglyceride lipase activity in thalassemia intermedia.
        IRCS Med. Sci. 1983; 11: 603
        • Weatherall D.J.
        • Clegg J.B.
        The Thalassemia Syndromes.
        in: Blackwell Scientific Publications, Oxford1981: 221
        • Rachmilewitz E.A.
        • Kahane I.
        The red blood cell membrane in thalassemia.
        Br. J. Haematol. 1980; 46: 1
        • Roeschlau P.
        • Bernt E.
        • Gruber W.
        Enzymatische Bestimmung des Gesamt-Cholesterols im Serum.
        Chem. Klin. Biochem. 1976; 12: 226
        • Wahlefeld A.W.
        Triglyceride determination after enzymatic hydrolysis.
        in: Methoden der Enzymatischen Analyse. vol. II. Verlag Chemie, Weinheim1974: 1878
        • Friedewald W.T.
        • Levy R.I.
        • Fredrickson D.S.
        Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge.
        Clin. Chem. 1972; 18: 499
        • Fessas P.
        • Stamatoyannopoulos G.
        • Keys A.
        Serum cholesterol and thalassemia trait.
        Lancet. 1963; 1: 1182
        • Pantelakis S.N.
        • Doxiadis S.A.
        Serum lipoproteins in schoolboys in relation to glucose phosphate dehydrogenase deficiency and thalassemia trait.
        Arch. Dis. Child. 1967; 42: 328
        • Koo C.
        • Wernette-Hammood M.E.
        • Garcia Z.
        • Malloy M.J.
        • Uauy R.
        • East C.
        • Billheimer D.W.
        • Mahley R.W.
        • Innerarity T.L.
        Uptake of cholesterol-rich lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors.
        J. Clin. Invest. 1988; 81: 1332